Abstract:Diagnostic approaches capable of ultrasensitive pathogen detection from low-volume clinical samples, running without any sophisticated instrument and laboratory setup, are easily field-deployable, inexpensive, and rapid, and are considered ideal for monitoring disease progression and surveillance. However, standard pathogen detection methods, including culture and microscopic observation, antibody-based serologic tests, and primarily polymerase chain reaction (PCR)-oriented nucleic acid screening techniques, have shortcomings that limit their widespread use in responding to outbreaks and regular diagnosis, especially in remote resource-limited settings (RLSs). Recently, clustered regularly interspaced short palindromic repeats (CRISPR)-based programmable technology has emerged to challenge the unmet criteria of conventional methods. It consists of CRISPR-associated proteins (Cas) capable of targeting virtually any specific RNA or DNA genome based on the guide RNA (gRNA) sequence. Furthermore, the discovery of programmable trans-cleavage Cas proteins like Cas12a and Cas13 that can collaterally damage reporter-containing single-stranded DNA or RNA upon formation of target Cas-gRNA complex has strengthened this technology with enhanced sensitivity. Current advances, including automated multiplexing, ultrasensitive single nucleotide polymorphism (SNP)-based screening, inexpensive paper-based lateral flow readouts, and ease of use in remote global settings, have attracted the scientific community to introduce this technology in nucleic-acid-based precise detection of bacterial and viral pathogens at the point of care (POC). This review highlights CRISPR-Cas-based molecular technologies in diagnosing several tropical diseases, namely malaria, zika, chikungunya, human immunodeficiency virus and acquired immunodeficiency syndrome (HIV-AIDS), tuberculosis (TB), and rabies.

Application of CRISPR/Cas12a in the rapid detection of pathogens

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid

CRISPR-Cas13: A new technology for the rapid detection of pathogenic microorganisms

Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)

Application of the CRISPR/Cas System in Pathogen Detection: A Review

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

Pathogen Detection Strategy Based on CRISPR

CRISPR Cas system: A strategic approach in detection of nucleic acids

CRISPR-Cas12a2-based rapid and sensitive detection system for target nucleic acid

Application of CRISPR/Cas Systems in the Nucleic Acid Detection of Infectious Diseases

[Application of CRISPR/Cas-based Biosensors for Detecting Nucleic Acid of Pathogens].

CRISPR-Cas13a system: A novel tool for molecular diagnostics

Advances in the application of recombinase-aided amplification combined with CRISPR-Cas technology in quick detection of pathogenic microbes

CRISPR-Based Programmable Nucleic Acid-Binding Protein Technology Can Specifically Detect Fatal Tropical Disease-Causing Pathogens

A field-deployable method for single and multiplex detection of DNA or RNA from pathogens using Cas12 and Cas13

A Programmable Sensitive Platform for Pathogen Detection Based on CRISPR/Cas12a -Hybridization Chain Reaction-Poly T-Cu

Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens

Versatile Detection with CRISPR/Cas System from Applications to Challenges

CRISPR: The Frontier Technology of Next-Generation RNA Detection

CRISPR molecular detection techniques: Advances from single to multiple detection methods

The CRISPR/Cas System: A Customizable Toolbox for Molecular Detection